Pages that link to "Q34132217"
Jump to navigation
Jump to search
The following pages link to Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis (Q34132217):
Displaying 50 items.
- Aberrations of TACC1 and TACC3 are associated with ovarian cancer (Q24811001) (← links)
- The disparate origins of ovarian cancers: pathogenesis and prevention strategies. (Q30240709) (← links)
- The preclinical natural history of serous ovarian cancer: defining the target for early detection (Q33487678) (← links)
- Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation (Q33633402) (← links)
- Tumors that mimic asbestos-related mesothelioma: time to consider a genetics-based tumor registry? (Q33687535) (← links)
- The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory (Q33739695) (← links)
- Serous tubal intraepithelial carcinoma upregulates markers associated with high-grade serous carcinomas including Rsf-1 (HBXAP), cyclin E and fatty acid synthase (Q33888942) (← links)
- Gynaecologic challenging issues in the management of BRCA mutation carriers: oral contraceptives, prophylactic salpingo-oophorectomy and hormone replacement therapy (Q34126089) (← links)
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers (Q34172655) (← links)
- Recent advances in the understanding of the pathogenesis of serous carcinoma: the concept of low- and high-grade disease and the role of the fallopian tube. (Q34201837) (← links)
- Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up (Q34313361) (← links)
- BRCA1: mechanisms of inactivation and implications for management of patients (Q34970470) (← links)
- Hereditary ovarian carcinoma: heterogeneity, molecular genetics, pathology, and management (Q34977063) (← links)
- Prophylactic surgery and other strategies for reducing the risk of familial ovarian cancer (Q35069343) (← links)
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm (Q35140600) (← links)
- Surgical advances in the treatment of ovarian cancer (Q35213226) (← links)
- Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer (Q35219159) (← links)
- Ovarian cancer and high-risk women—implications for prevention, screening, and early detection (Q35552356) (← links)
- Ovarian Cancer Is an Imported Disease: Fact or Fiction? (Q35878320) (← links)
- Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers. (Q35897417) (← links)
- Peritoneal carcinoma in women with genetic susceptibility: implications for Jewish populations (Q35934073) (← links)
- Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations (Q36111438) (← links)
- Shortened telomeres in serous tubal intraepithelial carcinoma: an early event in ovarian high-grade serous carcinogenesis (Q36652107) (← links)
- Clinical management recommendations for surveillance and risk-reduction strategies for hereditary breast and ovarian cancer among individuals carrying a deleterious BRCA1 or BRCA2 mutation (Q36754871) (← links)
- The heterogeneity of epithelial ovarian cancers: reconciling old and new paradigms (Q36810356) (← links)
- Management of the asymptomatic BRCA mutation carrier (Q36925172) (← links)
- Management options after prophylactic surgeries in women with BRCA mutations: a review (Q36959824) (← links)
- New insights into the pathogenesis of serous ovarian cancer and its clinical impact (Q37119411) (← links)
- Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention (Q37125079) (← links)
- Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC) (Q37163464) (← links)
- Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility (Q37416391) (← links)
- Genetic risk and gynecologic cancers. (Q37468316) (← links)
- Candidate serous cancer precursors in fallopian tube epithelium of BRCA1/2 mutation carriers. (Q37526389) (← links)
- Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations (Q37598303) (← links)
- Radical fimbriectomy: A reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development (Q37853691) (← links)
- BRCA carriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations (Q38039167) (← links)
- Müllerian intra-abdominal carcinomatosis in hereditary breast ovarian cancer syndrome: implications for risk-reducing surgery (Q38732720) (← links)
- Risk-reducing salpingectomy: Let us be opportunistic (Q39196159) (← links)
- Preclinical Models of Ovarian Cancer: Pathogenesis, Problems, and Implications for Prevention (Q39441988) (← links)
- Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. (Q40028239) (← links)
- Clinical implications of the breast cancer susceptibility genes BRCA1 and BRCA2. (Q43267049) (← links)
- Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations (Q44487666) (← links)
- Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomy. (Q45507609) (← links)
- Correlation of macroscopic and microscopic pathology in risk reducing salpingo-oophorectomy: Implications for intraoperative specimen evaluation (Q46109381) (← links)
- Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube (Q46366935) (← links)
- Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary (Q46904235) (← links)
- Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer (Q50760539) (← links)
- Occult endometrial cancer and decision making for prophylactic hysterectomy in hereditary nonpolyposis colorectal cancer patients. (Q51819338) (← links)
- Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers. (Q51842388) (← links)
- Ki-67 and p53 expression of the fallopian tube mucosa in breast cancer patients with hereditary risk. (Q54653872) (← links)